Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral research

Validation study of the prognostic and predictive value of TP53 signature for breast cancer Collateral research - Collateral research of validation study of TP53 signature

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042055

Enrollment

107

Registered

2020-10-09

Start date

2020-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Cases enrolled in "Validation study of the prognostic and predictive value of TP53 signature for breast cancer". Cases in which preoperative chemotherapy was administered.

Exclusion criteria

Exclusion criteria: Cases considered by the attending physician to be unsuitable for enrollment in this study

Design outcomes

Primary

Measure	Time frame
TP53 signature status after preoperative chemotherapy Overall survival Recurrence free survival	—

Countries

Japan

Contacts

Public ContactShin Takahashi

Tohoku University Hospital Department of Medical Oncology

shin.takahashi.e7@tohoku.ac.jp022-717-8543

Outcome results